Sharp Therapeutics Corp. Stock Price

TSXV:SHRX Community·CA$63.2m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

SHRX Share Price Performance

CA$2.10

0.45 (27.27%)

CA$2.10

0.45 (27.27%)

CA$2.10

Tue, 21 Apr 26

Share Pricen/a

SHRX Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Slight risk with mediocre balance sheet.

4 Risks

0 Rewards

View Full Analysis

Sharp Therapeutics Corp. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: -0.21
: 0%
: 0%
: 0%

View Full Analysis

About SHRX

Founded: n/a
Employees: n/a
CEO: Scott Sneddon
WebsiteView website: www.sharptx.com

Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies, enables discovery of compounds that correct the mutational defect; AlloChem, a compound library which binds proteins allosterically; and Mine, a proprietary IP-protected analytics platform that captures all data for all AlloChem compounds in all CoreX assays. Sharp Therapeutics Corp. is headquartered in Pittsburgh, Pennsylvania.